Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.52
-0.20 (-2.98%)
At close: Mar 20, 2026, 4:00 PM EDT
6.39
-0.13 (-1.99%)
After-hours: Mar 20, 2026, 7:54 PM EDT

Precision BioSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
34.2668.748.7325.1115.53
Revenue Growth (YoY)
-50.12%40.98%94.15%-78.28%375.72%
Gross Profit
34.2668.748.7325.1115.53
Selling, General & Admin
-32.24-35.3-39.09-41.28-39.67
Research & Development
-54.17-59.56-53.38-46.12-115.24
Other Operating Expenses
0.04----
Total Operating Expenses
-86.38-94.86-92.46-87.41-154.91
Operating Income
120.64163.55141.19112.5270.43
Total Non-Operating Income (Expense)
5.5433.331.21-10.68.77
Pretax Income
126.18196.88142.4101.9279.21
Net Income
-45.727.17142.4-111.64-30.6
Earnings From Discontinued Operations
0.89----
Net Income to Common
-45.727.17142.4-111.64-30.6
Net Income Growth
--94.97%---
Shares Outstanding (Basic)
137432
Shares Outstanding (Diluted)
137432
Shares Change (YoY)
86.32%79.20%31.11%49.77%12.79%
EPS (Basic)
-3.561.05-15.96-38.10-15.60
EPS (Diluted)
-3.561.04-15.96-38.10-15.60
Free Cash Flow
-65.93-58.7-86.07-49.07-15.91
Free Cash Flow Per Share
-5.14-8.53-22.41-16.75-8.13
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
352.09%238.08%289.76%448.26%234.08%
Profit Margin
368.26%286.60%292.24%406.02%241.68%
FCF Margin
-192.41%-85.44%-176.64%-195.52%-13.77%
EBITDA
122.11166.96148.01120.3279.42
EBITDA Margin
356.37%243.04%303.75%479.33%241.86%
EBIT
120.64163.55141.19112.5270.43
EBIT Margin
352.09%238.08%289.76%448.26%234.08%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q